UK and France establish joint biomedical research alliance focused on women's health and infectious disease
Five major research institutions across the UK and France have signed an agreement to combine expertise in artificial intelligence, advanced imaging, and clinical research to accelerate work on disease diagnosis and treatment. The partnership brings together the University of Oxford, Université Paris Cité, the Institut Pasteur, Diamond Light Source, and Synchrotron SOLEIL.
The UK-France Strategic Interdisciplinary Alliance in Health and AI addresses a specific problem: researchers generate vast amounts of biological and clinical data, but converting that information into faster diagnoses and better treatments remains difficult across institutions and borders. The alliance aims to make it easier for scientists to access the technologies, expertise, and datasets needed for complex disease research.
What the partnership covers
The alliance will focus initially on three areas:
- Women's health, including underdiagnosed conditions like endometriosis and pregnancy-related complications
- Pandemic preparedness and emerging infectious diseases
- Antimicrobial resistance and pathogenic threats
The collaboration integrates Oxford's work in structural biology and translational medicine, Université Paris Cité's interdisciplinary health research, the Institut Pasteur's infectious disease expertise, and the advanced imaging capabilities of both countries' synchrotrons-facilities that use synchrotron radiation to visualize biological structures at atomic scale.
How the structure works
The model combines discovery research with clinical expertise and advanced imaging at a national scale. Researchers will be able to connect molecular science through to population health data without navigating separate institutional systems.
Professor Philippe Guérin, Director of the Infectious Diseases Data Observatory at Oxford, said the alliance will allow researchers to "see disease in new ways" by combining two of the world's most powerful synchrotrons with research teams to understand how infections develop and respond to treatment in unprecedented detail.
The memorandum of understanding was signed at an executive committee meeting in France on May 27, 2026.
Learn more about AI for Science & Research and AI for Healthcare.
Your membership also unlocks:
